Who would have thought? An anti-malarial medication having potential as adjunctive treatment of type 2 diabetes. Yes, hydroxychloroquine (Plaquenil) provided similar hemoglobin A1c reduction as canagliflozin when added to vildagliptin and metformin in persons with diabetes unable to achieve glycemic goals. To learn more, please click on link below.
Please share your thoughts and subscribe to receive my blogs.
#hydroxycholoroquine #adjunctive # treatment #type2diabetes
Follow me on Twitter and Facebook @ReecesPiecesDi and Instagram ReecesPiecesDI.